Report estimates state-level economic costs of opioid use disorder and fatal overdose

A report provided estimates of state-level economic costs associated with opioid use disorder and fatal opioid overdose across the United States. The analysis examined costs at the state level, but the specific population size, time period, and data sources were not reported. No intervention or comparator was described in the available information.

The main results for economic costs were not reported, including total or per-capita figures, effect sizes, confidence intervals, or statistical significance. The direction of findings or comparisons between states were also not provided. Safety and tolerability data were not applicable to this economic analysis.

Key limitations include the absence of reported methodology, making it impossible to assess the quality of cost estimation or potential biases. The funding sources and author conflicts of interest were not reported. For clinical practice, this report highlights the economic burden of the opioid crisis but provides insufficient detail to inform specific policy or treatment decisions without access to the full methodology and results.